Adhd and Hypercoagulation

Summary:

Hypercoagulation is found among people with Adhd, especially for people who are female, 20-29 old.

The study analyzes which people have Hypercoagulation with Adhd. It is created by eHealthMe based on reports of 12 people who have Adhd from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Adhd?

Adhd (adhd-mental disorders that develop in children) is found to be associated with 608 drugs and 1,369 conditions by eHealthMe. Check the latest studies of Adhd.

What is Hypercoagulation?

Hypercoagulation (increased tendency for clotting of the blood) is found to be associated with 446 drugs and 533 conditions by eHealthMe. Check the latest studies of Hypercoagulation.

On Oct, 09, 2025

12 people who have Adhd and Hypercoagulation are studied.

Would you have Hypercoagulation when you have Adhd?

Gender of people who have Adhd and experienced Hypercoagulation *:

female: 90 %
male: 10 %

Age of people who have Adhd and experienced Hypercoagulation *:

Common co-existing conditions for these people *:

Birth Control: 7 people, 58.33%
Pain: 2 people, 16.67%
Ovarian Cysts (fluid filled sacs of the ovary): 2 people, 16.67%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 2 people, 16.67%
Dysmenorrhea (painful menstruation): 2 people, 16.67%
Stress And Anxiety: 1 person, 8.33%
Menstrual Disorder (disease of menstrual cycle): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Back Pain: 1 person, 8.33%

Common drugs taken by these people *:

Nuvaring: 5 people, 41.67%
Lisdexamfetamine Dimesylate: 4 people, 33.33%
Concerta: 3 people, 25.00%
Norgestimate And Ethinyl Estradiol: 2 people, 16.67%
Vicodin: 1 person, 8.33%
Sertraline Hydrochloride: 1 person, 8.33%
Ritalin: 1 person, 8.33%
Percocet: 1 person, 8.33%
Ortho Evra: 1 person, 8.33%
Morphine: 1 person, 8.33%

Common symptoms for these people *:

Pulmonary Embolism (blockage of the main artery of the lung): 5 people, 41.67%
Insomnia (sleeplessness): 3 people, 25.00%
Weakness: 2 people, 16.67%
Cervix Carcinoma (cancer of cervix): 2 people, 16.67%
Hypersensitivity: 2 people, 16.67%
Vulvovaginal Discomfort: 2 people, 16.67%
Kidney Infection: 2 people, 16.67%
Lung Neoplasm (tumour of lung): 2 people, 16.67%
Dysfunctional Uterine Bleeding (Dub): 2 people, 16.67%
Maternal Exposure Before Pregnancy (use of substance before pregnancy): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hypercoagulation?

Check whether Hypercoagulation is associated with a drug or a condition

Related publications that referenced our studies

Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .

Related studies:

Treatments, associated drugs and conditions:

Adhd (120,225 reports)
Hypercoagulation (4,011 reports)

All the drugs that are associated with Hypercoagulation:

Hypercoagulation (446 drugs)

All the conditions that are associated with Hypercoagulation:

Hypercoagulation (533 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hypercoagulation and Adhd, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.